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Abstract
Background: Hepatitis B virus (HBV) infection can lead to chronic hepatitis, liver 
cirrhosis, and Hepatocellular Carcinoma (HCC). Vaccination against the virus plays an 
important role in its prevention. Health personnel at risk of infection are recommended 
to receive the vaccine and to check their immune status thereafter.
Objective: To determine Hepatitis B Immune status among vaccinated health 
personnel in Khartoum state, Sudan. A total of 106 health personnel from different 
hospitals and doctors’ mess in Khartoum and from different jobs were surveyed 
and their HBV surface antibodies levels were determined by HBsAb (Quantitative) 
ELISA Kits.
Methods: Of the 106 participants in this study, the majority were females 72.6%. 
The mean age of those involved was 27.69 years, and nurses made for more 
than 50% of those surveyed. About 56.6% (60) of the health personnel involved 
took three or more doses of HBV vaccine while the rest received one or two 
doses. The results of the participants who received three or more doses of 
the vaccine represented immunity by 70%. In general, about 47.2% (50) of the 
participants in this study did show excellent immune response (>100 mIU/mL) 
and 18.9% (20) had weak protective levels (between 10 and 100 mIU/mL) 
So, we concluded that HBV post-vaccination immunity status of health personnel 
in Khartoum state is lower than post-vaccination HBV immunity in other parts of the 
world. There is an urgent need for a national protocol of HBV vaccination to improve 
the immunization status of health personnel with a regular checkup of HBV immunity 
and easy access to a good-quality vaccine.
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Introduction
Hepatitis B Virus (HBV) is a member of the Hepadnaviridae family with a small DNA 
virus and unusual features of replication similar to retroviruses, in which HBV can 
replicate through an RNA intermediate and forming a stable minichromosome (cccDNA) 
in the nucleus. These features of the HBV replication cycle give it the ability to persist in 
infected cells [1]. HBV can cause acute hepatitis and can also lead to other more serious 
complications like Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma 
(HCC) [2]. HBV can survive outside the body for up to seven days; the virus incubation 
period is around two and a half months. The virus can be transmitted perinatally from 
a mother to her baby, horizontally by exposure to infected blood or blood products, or 
through direct spread percutaneously or to mucosal membranes [3]. HBV infects more 
than 300 million people worldwide; Sudan is classified among the countries with high 
HBV seroprevalence. Exposure to the virus varied from 47 to 78%, with a hepatitis B 
surface antigen prevalence ranging from 6.8% in central Sudan to 26% in southern 
Sudan [4]. HBV vaccine is a recombinant DNA vaccine that contains HBsAg genetically 
engineered from the yeast Saccharomyces cerevisiae. It provides a seroprotection rate 
of 85–100% that was seen one month after the last dose of vaccine and it confers 
immunity for at least 10 years [5]. Hepatitis B vaccine is recommended for unvaccinated 
adults who are at risk for HBV infection like people whose sex partners have hepatitis B, 
sexually active persons who are not in a long-term monogamous relationship, persons 
seeking evaluation or treatment for a sexually transmitted disease, men who have sex 
with men, people who share needles, syringes, or other drug-injection equipment, 
household contacts of HBV-infected persons, health personnel and public safety 
workers at risk for exposure to blood or body fluids, residents and staff of facilities for 
developmentally disabled persons, persons in correctional facilities, victims of sexual 
assault or abuse, travelers to regions with increased rates of hepatitis B, people with 
chronic liver disease, patients on hemodialysis, HIV infection, or diabetes, and anyone 
who wants to be protected from HBV. The vaccine is usually given as three shots over 
a period of a six-month period [6]. Serum antibody to the hepatitis B surface antigen 
(anti-HBs) has long been established as a marker of vaccine-induced protection against 
hepatitis B. An anti-HBs level of ≥10 IU/ml has been suggested to indicate protection 
against hepatitis B disease [7]. Old age in adults, male gender, increased body mass 
index, smoking, and concomitant disease are some of the factors that may decrease 
the immunologic response to HBV vaccine [8]. This study was conducted to determine 
hepatitis B immune status among vaccinated health personnel in Khartoum, Sudan.
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Materials and Methods
This is a descriptive cross-sectional study conducted at public hospitals of Khartoum 
including the Ibn Sina Specialized Hospital, the Alshaab Teaching Hospital, and the 
Academic Hospital from 30th July to 30th September 2017. The study included healthcare 
providers working in all departments, including trained nurses, medical attendants, and 
clinicians – both surgical and medical-related specialties and laboratory technicians. 
The investigator approached healthcare workers through the hospital administration 
and the heads of the departments. A self-administered questionnaire that covered 
age, gender, job description, total doses of vaccine and the date of the last dose plus 
other data such as duration since the last dose and a history of immunosuppressive 
treatment and blood transfusion was used to obtain information from the participants. 
The questionnaires were collected from the healthcare workers upon completion by 
appointment with the participant; 5 ml venous blood sample was collected from the 
cubital vein under complete possible aseptic conditions in EDTA containers, centrifuged 
at 3000 rounds per min for 10 min to be separated and stored at –20ºC till it was used.
The ELISA procedure was followed according to the manufacturer’s instructions. 
In brief, 50 μl of the serum were incubated at 37ºC for 60 min in 118-well microplate 
coated with HBsAg reactive to HBsAb (anti-HBs). Subsequently, the wells were washed 
(three times) to remove residual serum. 50 μl of anti-HBs conjugated AB was added and 
incubated at 37ºC for 60 min. The wells were washed (three times) to eliminate unbound 
conjugate, 50 μl of enzyme-substrate and chromogen were added and incubated at 
37ºC for 60 min; 50 μl diluted stop solution (Sulphuric acid) was added and the plate 
was read at 450 nm as indicated by the manufacturer.
Interpretation of the result
The cut-off value was estimated by calculating the mean (m) absorbance value of 
negative control x 2.1.
Cut-off = mean of the negative control x 2.1
For the validity of the accomplishment, the following is required:
(a)  Negative control means: absorbance of individual negative control values must 
be <0.9
(b) Positive control means: it must be >1.1
(c)  Equivocal means: absorbance of individual equivocal values must be between 0.9 
and 1.1. All statistical calculations were done using SPSS for Windows, version 24.
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Results
A total of 106 health personnel participated in this study, of those, 77 (72.6 %) were females 
and 29 (27.4%) males with a female:male ratio of 2.65:1. The mean age of the participants 
was 27.69 years, the minimum age was 20 years, and the maximum age was 55 years.
Furthermore, 56 (52.8%) participants were nurses by profession, 35 (33%) were 
doctors, 4 (3.7%) lab technicians, and 11 (10.4%) others. 
About 97 (91.5%) participants took the last dose of vaccine within the past 10 years 
and 12 (11.3%) took their vaccine during childhood. 
The number of subjects who completed the all three doses of vaccine or more were 
60 (56.6%), those who took two doses were 23 (21.7%), and those with only one dose 
were 23 (21.7%), see Table 1. 
Table 1: Total Number of HBV Vaccine Doses Received vs Immunity Acquired After Each Dose.
Number of HBV Vaccine 
Doses Received
Frequency Percent Valid Percent
1 dose 5.20 + 1.31 4.28 + 0.88 0.0076
2 doses 2.03 + 1.43 1.26 + 0.76 0.0271
3 doses 3.06 + 0.73 2.60 + 0.56 0.0248
>3 doses 1.12 + 0.29 1.20 + 0.24 0.2736
Total 106 100% 100%
Sixty participants completed the three or more doses of vaccine, about forty two 
(66%) had HBsAbs titer ≥10 mIU/mL and eighteen (30%) had titer <10 mIU/mL. Of those 
who took two doses of the vaccine, 17 (73.9%) had HBsAbs titer >10 mIU/L and 6 (26.1%) 
<10 mIU/mL. And of those who received one dose, 12 (52.1%) had titer <10 mIU/mL and 
11 (47.8%) ≥10 mIU/mL (Figure 1).
About 34 (32%) participants were exposed to needle stick injury during their work 
but didn’t received treatment, 3 (8.8%) had undergone blood transfusion, and 1 had 
received Hepatitis B Immunoglobulin after accidental needle injury from Hepatitis 
B-infected patient and her HBsAb result was excellent at 191.0 mIU/mL (Figure 2).
Discussion
HCWs are at a higher risk of blood-borne infections, especially HBV. Vaccination is 
effective in protecting 90–95% of adults [9]. According to the World Health Organization 
(WHO) estimate, hepatitis B vaccination coverage among healthcare workers varies 
from 18% being lowest in Africa to the highest 77% in Australia and New Zealand [10]. 
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Figure 1: Distribution of Subjects Participating in this Study According to Specialty in Which Nurses (56) 
Were More than all the Other Groups.
Figure 2: Correlation Between HBsAb Titer and Number of Participants Receiving Different 
Doses of HBV Vaccine (p = 0.035).
In this study, we examined the level of anti-HBsAb in healthcare personnel in three 
public hospitals in Khartoum state besides Khartoum doctors’ mess; the hospitals were 
the Ibn Sina Specialized Hospital, the Alshaab Teaching Hospital, and the Academic 
Teaching Hospital. They were chosen mainly because of their easy accessibility. In this 
study, 60 (56.6%) participants completed all three doses of vaccine, which is higher 
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compared to the lower vaccination rates found in the other two studies conducted in 
Ethiopia, one in the Gondar University Hospital (28.7%) [11] and the other at the Adama 
General Hospital and Medical College (25.6%) [12] while nearly similar results as ours 
was seen in a study conducted in the Makueni County of Kenya (48%) [13]. Another 
study reveals a higher percentage of full vaccination (72%) in Libya [14]. 
From our results, we notice that there is a direct relationship between the numbers of 
doses the participants received and their immune status against HBV (p = 0.035), so those 
who received three or more doses of the vaccine, their results represented immunity by 
70%. On the other hand, just 47.8% of those who took one dose of HBV vaccine in their 
lifetime are immune to the virus (Table 1). In our study about 70% of the subjects were 
immuned after receiving at least three doses of the vaccine which is lower than the study 
done in West Pomeranian Region of Poland (94.5%) [15]. Another finding in this study was 
that there is no big difference in HBV immunity between those who took their last dose 
of the vaccine <10 years ago (64.95% are immune) and the participants who took their 
last vaccine dose ≥10 years ago (77.8% are immune). In general, about 47.2% (50) of the 
participants in this study did show excellent immune response (>100 mIU/mL), 18.9% (20) 
had weak protective levels (between 10 and 100 mIU/mL) which in comparison to the 
Lasemi, Eshagh et al’s study, were a little bit higher as in their study, 54% of the students 
had an excellent protective immune response and 24.2% had a positive but weak immune 
response [16]. Some suggest that the weak immune response among health personnel 
in Sudan may be due to the type of vaccine that is used, which is an imported vaccine 
from outside the country. No official data about the type of vaccine are available from the 
National Medical Supplies Fund (NMSF). Only 56.6% of the involved health personnel 
finished the recommended three doses that reflects the gap in the health education and 
awareness about HBV vaccination among health personnel. This may be due to the high 
cost and lack of a public protocol for health personnel HBV vaccination, we found only 
two previous researches close to this topic in Sudan [17]. It is worth mentioning that most 
participants 56 (52.8%) were nurses, who were more willing to get involved and check 
their HBsAb levels than doctors. 
About 70 (66.0%) participants were surveyed at the Ibn Sina Hospital; they were 
eager to get involved because they wanted to know their immune status against HBV as 
the hospital is the main referral hospital for gastroenterology and hepatology in Sudan. 
They have better awareness about the importance of vaccination against the HBV and 
their increased risk of acquiring the disease if they don’t have immunity against the 
virus especially with the high numbers of hepatitis B patients in their hospital. 
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Conclusion
From this research, we can conclude that HBV post-vaccination immunity status of 
health personnel in Khartoum state is lower than the post-vaccination HBV immunity 
in other parts of the world. So, there is an urgent need for a national protocol of HBV 
vaccination to improve the immunization status of healthcare workers that includes 
regular checkups of HBV immunity and easy access to a good-quality vaccine. 
To get more accurate results of the response to the hepatitis B vaccine among 
healthcare workers in Sudan, more large-scale studies should be conducted. 
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